Advisory Research’s Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share ACAQ.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAQ.WS
LP
RCM
HCM
SCM
PC
CCA
SCM
ACM
HIM
PSAMP
Advisory Research's ACAQ.WS Position: Q4 2022 in Review
Advisory Research sold out of Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share (ACAQ.WS) in Q4 2022, closing a stake of 82,000 shares — an estimated $4K sold.
Advisory Research first reported a position in ACAQ.WS in Q4 2021 and held it in 4 quarters. The position peaked at $44K in Q4 2021. 43 funds tracked by Wall St. Rank hold ACAQ.WS as of Q4 2022.
- Advisory Research reported no remaining Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Advisory Research sold 82,000 Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share shares in Q4 2022, an estimated $4K.
- Advisory Research first reported a position in Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share in Q4 2021 and held it in 4 quarters.
- Advisory Research's Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share position peaked at $44K in Q4 2021.
- 43 funds tracked by Wall St. Rank held Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share as of Q4 2022.
Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.